Evidence map›Paper›PMID 36173189›Full record

ArticleJournal of virology2022

Unique Evolution of Antiviral Tetherin in Bats.

Joshua A Hayward, Mary Tachedjian, Adam Johnson, Aaron T Irving, Tamsin B Gordon, Jie Cui, Alexis Nicolas, Ina Smith, Victoria Boyd, Glenn A Marsh and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Extensive longevity and DNA virus-driven adaptation in nearcticbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Antiviral effects of interferon-stimulated genes in bats.Frontiers in cellular and infection microbiology · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Joshua A HaywardHealth Security Program, Life Sciences Discipline, Burnet Institutegrid.1056.2, Melbourne, Victoria, Australia.ORCID 0000-0003-3904-3051
Mary TachedjianCSIRO, Australian Centre for Disease Preparednessgrid.413322.5, Health and Biosecurity Business Unit, Geelong, Victoria, Australia.
Adam JohnsonHealth Security Program, Life Sciences Discipline, Burnet Institutegrid.1056.2, Melbourne, Victoria, Australia.
Aaron T IrvingZhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University International Campus, Haining, Zhejiang, China.
Tamsin B GordonHealth Security Program, Life Sciences Discipline, Burnet Institutegrid.1056.2, Melbourne, Victoria, Australia.
Jie CuiCAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghaigrid.429007.8, Chinese Academy of Sciences, Beijing, China.
Alexis NicolasCSIRO, Australian Centre for Disease Preparednessgrid.413322.5, Health and Biosecurity Business Unit, Geelong, Victoria, Australia.
Ina SmithCSIRO, Health and Biosecurity Business Unit, Acton, Australian Capital Territory, Australia.
Victoria BoydCSIRO, Australian Centre for Disease Preparednessgrid.413322.5, Health and Biosecurity Business Unit, Geelong, Victoria, Australia.
Glenn A MarshCSIRO, Australian Centre for Disease Preparednessgrid.413322.5, Health and Biosecurity Business Unit, Geelong, Victoria, Australia.
Michelle L BakerCSIRO, Australian Centre for Disease Preparednessgrid.413322.5, Health and Biosecurity Business Unit, Geelong, Victoria, Australia.
Lin-Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0003-2752-0535
Gilda TachedjianHealth Security Program, Life Sciences Discipline, Burnet Institutegrid.1056.2, Melbourne, Victoria, Australia.ORCID 0000-0002-7733-7037
Commonwealth Scientific and Industrial Research Organisation · AUBurnet Institute · AUChinese Academy of Sciences · CNCSIRO Health and Biosecurity · AUDuke-NUS Medical School · SGThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bats are recognized as important reservoirs of viruses deadly to other mammals, including humans. These infections are typically nonpathogenic in bats, raising questions about host response differences that might exist between bats and other mammals. Tetherin is a restriction factor which inhibits the release of a diverse range of viruses from host cells, including retroviruses, coronaviruses, filoviruses, and paramyxoviruses, some of which are deadly to humans and transmitted by bats. Here, we characterize the tetherin genes from 27 bat species, revealing that they have evolved under strong selective pressure, and that fruit bats and vesper bats express unique structural variants of the tetherin protein. Tetherin was widely and variably expressed across fruit bat tissue types and upregulated in spleen tissue when stimulated with Toll-like receptor agonists. The expression of two computationally predicted splice isoforms of fruit bat tetherin was verified. We identified an additional third unique splice isoform which includes a C-terminal region that is not homologous to known mammalian tetherin variants but was functionally capable of restricting the release of filoviral virus-like particles. We also report that vesper bats possess and express at least five tetherin genes, including structural variants, more than any other mammal reported to date. These findings support the hypothesis of differential antiviral gene evolution in bats relative to other mammals.

Indexed as

ChiropteraVirus DiseasesVirusesAnimalsAntiviral AgentsBone Marrow Stromal Antigen 2HumansToll-Like ReceptorsAntiviral AgentsBone Marrow Stromal Antigen 2Toll-Like ReceptorsantiviralbatsBST-2evolutionfilovirusesinnate immunityrestriction factorsretrovirusestetherinviruses

Identifiers

PMID36173189
PMCPMC9599465
OpenAlexW4297965184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.